Don't Use Baloxavir to Treat Patients Hospitalized With the Flu

December 2018

Baloxavir (Xofluza, zoh-FLOO-zuh) will be the first new oral antiviral for treating influenza in nearly 20 years.

Think of baloxavir as an alternative to oseltamivir (Tamiflu)...but with a new antiviral mechanism. Both baloxavir and oseltamivir reduce flu symptoms by about a day in otherwise healthy patients...if started within 48 hours of onset.

But baloxavir is ONE oral dose...compared to 5 days of BID oseltamivir. Baloxavir also seems to cause less nausea and vomiting.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote